Bojarska Joanna, Breza Martin, Jelemenska Ingrid, Madura Izabela, Jafari Sepideh, Kaczmarek Krzysztof, Ziora Zyta, Wolf Wojciech
Department of Chemistry, Institute of Inorganic and Ecological Chemistry, Technical University of Lodz, Lodz, Poland.
STU, Physical Chemistry, Bratislava, SK, Slovak Technical University, Bratislava, Slovakia.
R Soc Open Sci. 2025 Sep 24;12(9):251026. doi: 10.1098/rsos.251026. eCollection 2025 Sep.
This study presents the synthesis and comprehensive characterization of a novel, modified ultra-short peptide, Ac-Phe-Aib-Deg-OH (-acetyl--phenylalanyl-α-aminoisobutyrylα,α-diethylglycine), (), highlighting its potential as an anticancer ligand for G protein-coupled receptors (GPCRs). The structure of the compound was elucidated using single-crystal X-ray crystallography, revealing its pseudo-macrocyclic nature. Hydrogen bonds and dispersion forces drive the hierarchical supramolecular self-assembly of (). A comparative analysis with structurally similar structures, that is, achatin derived from the Cambridge Structural Database, was conducted using diverse methods. A detailed analysis of intra- and intermolecular interactions in the structures, especially using modern structural database-driven techniques, provides further insight into the preferential bonding mode of () as a potential drug candidate. Density functional theory calculations were performed to rationalize the interactions and reactivity of the molecules. To validate the predicted anticancer activity of the analysed molecules, we evaluated the binding affinities of these molecules to cancer-related GPCRs. We examined the interaction maps using molecular docking analysis with targets associated with various types of cancer. These findings suggest that () could be a promising candidate for future studies on designing innovative pseudo-macrocyclic ultra-short peptides containing unnatural amino acids for new targeted anticancer therapy.
本研究介绍了一种新型修饰超短肽Ac-Phe-Aib-Deg-OH(-乙酰基--苯丙氨酰-α-氨基异丁酰基α,α-二乙基甘氨酸)的合成及全面表征,强调了其作为G蛋白偶联受体(GPCR)抗癌配体的潜力。使用单晶X射线晶体学阐明了该化合物的结构,揭示了其假大环性质。氢键和色散力驱动了()的分级超分子自组装。使用多种方法对与结构相似的结构(即源自剑桥结构数据库的玛瑙螺毒素)进行了比较分析。对结构中的分子内和分子间相互作用进行详细分析,尤其是使用现代结构数据库驱动技术,进一步深入了解了()作为潜在药物候选物的优先键合模式。进行了密度泛函理论计算以合理化分子的相互作用和反应性。为了验证所分析分子的预测抗癌活性,我们评估了这些分子与癌症相关GPCR的结合亲和力。我们使用与各种类型癌症相关的靶点进行分子对接分析来检查相互作用图谱。这些发现表明,()可能是未来研究的一个有前途的候选物,用于设计含有非天然氨基酸的创新假大环超短肽以进行新的靶向抗癌治疗。